CVE-2021-23877
Privilege escalation vulnerability in the Windows trial installer of McAfee Total Protection (MTP) prior to 16.0.34_x may allow a local user to run arbitrary code as the admin user by replacing a specific temporary file created during the installation…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.37%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Privilege escalation vulnerability in the Windows trial installer of McAfee Total Protection (MTP) prior to 16.0.34_x may allow a local user to run arbitrary code as the admin user by replacing a specific temporary file created during the installation of the trial version of MTP.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.37% probability · 30th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-269
- Affected
- mcafee/total protection
- Source
- trellixpsirt@trellix.com
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.